Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Breast 1

Conditions

Barrett Esophagus 6Stomach Neoplasms 4Gastritis 3Zollinger-Ellison Syndrome 2Stomach Ulcer 2Peptic Ulcer 2Esophageal Neoplasms 2Dyspepsia 2Colorectal Neoplasms 2Breast Neoplasms 2Precancerous Conditions 1Neoplasms 1Neoplasm Metastasis 1Multiple Endocrine Neoplasia Type 1 1Lymphoma 1Hot Flashes 1Hemorrhage 1Head and Neck Neoplasms 1Gastrointestinal Stromal Tumors 1Gastroesophageal Reflux 1Gastritis Dyspepsia Helicobacter Pylori Infection Gastric Cancer Peptic Ulcer 1Esophagitis, Peptic 1Colonic Neoplasms 1Advanced Non-small Cell Lung Cancer 1

Interventions

Gemcitabine 74Capecitabine 60Paclitaxel 59Fluorouracil 58Oxaliplatin 57Bevacizumab 51Docetaxel 50Leucovorin 48Nivolumab 40Cisplatin 40Irinotecan 39Carboplatin 37Cetuximab 34pembrolizumab 32Radiosurgery 32Trastuzumab 30Radiotherapy 27Everolimus 24Sorafenib 23Pemetrexed 20Doxorubicin 20Albumin-Bound Paclitaxel 20Ipilimumab 19Cyclophosphamide 19Panitumumab 18Zoledronic Acid 17Lapatinib 17Erlotinib Hydrochloride 17Prednisone 16pazopanib 15

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Completed × Neoplasm Metastasis × Esomeprazole × Clear all
NCT01069081 2015-03-06

Docetaxel and Cisplatin Chemotherapy With or Without High Dose Proton Pump Inhibitor in Metastatic Breast Cancer

Fudan University

Phase 2 Completed
94 enrolled
Breast

Breast Neoplasms, Neoplasm Metastasis

Data powered by HemOnc (CC BY 4.0) Colophon âš¡